NEW YORK (GenomeWeb News) – Thermo Fisher Scientific informed about 230 employees earlier this year that their jobs are being eliminated, the company disclosed in a document filed with the US Securities and Exchange Commission last week.

In its Form 10-Q, Thermo Fisher said that its severance costs totaled $10 million for the first quarter ended March 31 for the job cuts across all three of its segments — Analytical Technologies, Specialty Diagnostics, and Laboratory Products and Services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.